• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Eaton Vance Worldwide Health Sciences Fund

+ Add to Watchlist

ETHSX:US

13.23 USD 0.12 0.90%

As of 09:29:30 ET on 10/01/2014.

Snapshot for Eaton Vance Worldwide Health Sciences Fund (ETHSX)

Year To Date: +17.70% 3-Month: +3.28% 3-Year: +27.20% 52-Week Range: 10.06 - 13.59
1-Month: -1.19% 1-Year: +26.39% 5-Year: +18.65% Beta vs SPX: 0.93

Mutual Fund Chart for ETHSX

No chart data available.
  • ETHSX:US 13.23
  • 1M
  • 1Y
Interactive ETHSX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ETHSX

Eaton Vance Worldwide Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital growth. The Fund invests at least 80% of its net assets in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care.

Inception Date: 07-26-1985 Telephone: 1-617-482-8260
Managers: SAMUEL DAVID ISALY / SVEN H BORHO
Web Site: www.eatonvance.com

Fundamentals for ETHSX

NAV (on 2014-10-01) 13.23
Assets (M) (on 2014-08-29) 1,484.84
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 0.00

Dividends for ETHSX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2013-12-17) 0.20
Dividend Yield (ttm) 10.84

Fees & Expenses for ETHSX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 0.91
Redemption Fee 1.00
12b1 Fee 0.25
Expense Ratio 1.39

Top Fund Holdings for ETHSX

Filing Date: 07/31/2014
Name Position Value % of Total
Roche Holding AG 293,000 85,030,233 6.028%
HCA Holdings Inc 1,055,000 68,902,050 4.884%
Bristol-Myers Squibb Co 1,230,000 62,262,600 4.414%
AbbVie Inc 1,140,000 59,667,600 4.230%
Gilead Sciences Inc 600,000 54,930,000 3.894%
Merck & Co Inc 932,000 52,881,680 3.749%
Biogen Idec Inc 149,600 50,024,744 3.546%
Amgen Inc 392,000 49,936,880 3.540%
Regeneron Pharmaceuticals Inc 132,500 41,899,150 2.970%
Actelion Ltd 348,000 41,796,837 2.963%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil